181 related articles for article (PubMed ID: 34918325)
21. Vaccination of Pregnant Women Against COVID-19.
Abu-Raya B
Neoreviews; 2021 Sep; 22(9):e570-e573. PubMed ID: 34470758
[TBL] [Abstract][Full Text] [Related]
22. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies.
Sánchez-Zuno GA; Matuz-Flores MG; González-Estevez G; Nicoletti F; Turrubiates-Hernández FJ; Mangano K; Muñoz-Valle JF
Int J Immunopathol Pharmacol; 2021; 35():20587384211050199. PubMed ID: 34632844
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 associated pathogenesis, immune dysfunction and involvement of host factors: a comprehensive review.
Waqar W; Ismail S; Jamil Z; Al-Shehhi A; Imran M; Hetta HF; Muhammad K; Waheed Y
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7526-7542. PubMed ID: 34919255
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
Wong RSY
Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786
[TBL] [Abstract][Full Text] [Related]
26. COVID-19 Reinfection in An Immunosuppressed Patient Without An Antibody Response.
Hunsinger DHP; Kutti Sridharan DG; Rokkam DVRP; Fantry DLE
Am J Med Sci; 2021 Jul; 362(1):103. PubMed ID: 33612185
[No Abstract] [Full Text] [Related]
27. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.
Thng ZX; De Smet MD; Lee CS; Gupta V; Smith JR; McCluskey PJ; Thorne JE; Kempen JH; Zierhut M; Nguyen QD; Pavesio C; Agrawal R
Br J Ophthalmol; 2021 Mar; 105(3):306-310. PubMed ID: 32532764
[TBL] [Abstract][Full Text] [Related]
28. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
29. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection.
Sui Z; Dai X; Lu Q; Zhang Y; Huang M; Li S; Peng T; Xie J; Zhang Y; Wu C; Xia J; Dong L; Yang J; Huang W; Liu S; Wang Z; Li K; Yang Q; Zhou X; Wu Y; Liu W; Fang X; Peng K
Signal Transduct Target Ther; 2021 May; 6(1):181. PubMed ID: 33972497
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 in Kidney Transplant Patients From a Large UK Transplant Center: Exploring Risk Factors for Disease Severity.
Sran K; Olsburgh J; Kasimatis T; Clark K; Gökmen R; Hilton R; Shah S; Shaw C; Farmer C; Kilbride H; Asgari E
Transplant Proc; 2021 May; 53(4):1160-1168. PubMed ID: 33483166
[TBL] [Abstract][Full Text] [Related]
31. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
32. The role of vaccines in the COVID-19 pandemic: what have we learned?
Krammer F
Semin Immunopathol; 2024 Jan; 45(4-6):451-468. PubMed ID: 37436465
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.
Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP
mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130
[TBL] [Abstract][Full Text] [Related]
34. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
Sharma D
Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
[TBL] [Abstract][Full Text] [Related]
35. An Overview on COVID-19 and its Effect on Cardiovascular Diseases.
Hamadi A; Mahzari A; Hakami A; Hindawi S; Dobie G; Sayyed MI; Hamdi F; Nahari M; Jackson DE
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1949-1953. PubMed ID: 33371840
[TBL] [Abstract][Full Text] [Related]
36. Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider?
Arnold CG; Monte AA; Littlefield K; Vest A; Palmer BE
Viral Immunol; 2021 Dec; 34(10):666-668. PubMed ID: 34491119
[No Abstract] [Full Text] [Related]
37. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
[No Abstract] [Full Text] [Related]
38. SARS-CoV2 and immunosuppression: A double-edged sword.
Lai Q; Spoletini G; Bianco G; Graceffa D; Agnes S; Rossi M; Lerut J
Transpl Infect Dis; 2020 Dec; 22(6):e13404. PubMed ID: 32639598
[TBL] [Abstract][Full Text] [Related]
39. Management of immunosuppressants in the era of coronavirus disease-2019.
Manansala M; Baughman R; Novak R; Judson M; Sweiss N
Curr Opin Pulm Med; 2021 May; 27(3):176-183. PubMed ID: 33779588
[TBL] [Abstract][Full Text] [Related]
40. The Role of Nutrition During the COVID-19 Pandemic: What We Know.
Vitale E; Magrone M; Galatola V; Magrone T
Endocr Metab Immune Disord Drug Targets; 2021; 21(11):1982-1992. PubMed ID: 33459251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
